Hong Kong stocks fluctuate | Genescience Pharmaceuticals (02566.HK) rises over 6% as the recent approval of Malay acetic acid Avapritinib by the National Medical Products Administration for listing.

According to the Wise Finance and Economics APP, Nine Source Genetics (02566.HK) has risen by more than 6%, as of the time of writing, up by 6.27%, to 9.66 Hong Kong dollars, with a trading volume of 8.5232 million Hong Kong dollars.